Cited by 263Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchAnimal Virus Infections Studies

The DOI matches its Crossref record; 297 of the 297 references it cites were found in a registry or an index.

Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

Open access

Koelle, David M., Corey, Lawrence·2003·Clinical Microbiology Reviews

DOI 10.1128/cmr.16.1.96-113.2003PMC PMC145296

Open this paper in CoChat — free account

Abstract

SUMMARY: Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) cause prevalent, chronic infections that have serious outcomes in some individuals. Neonatal herpes may occur when the infant traverses the cervix during maternal genital herpes. Genital herpes is a major risk factor for human immunodeficiency virus type 1 transmission. Considerable efforts have been made to design and test vaccines for HSV, focusing on genital infection with HSV-2. Several protein subunit vaccines based on HSV-2 envelope glycoproteins have reached advanced-phase clinical trials. These antigens were chosen because they are the targets of neutralizing-antibody responses and because they elicit cellular immunity. Encouraging results have been reported in studies of treatment of HSV-seronegative women with a vaccine consisting of truncated glycoprotein D of HSV-2 and a novel adjuvant. Because most sexual HSV transmission occurs during asymptomatic shedding, it is important to evaluate the impact of vaccination on HSV-2 infection, clinically apparent genital herpes, and HSV shedding among vaccine recipients who acquire infection. There are several other attractive formats, including subunit vaccines that target cellular immune responses, live attenuated virus strains, and mutant strains that undergo incomplete lytic replication. HSV vaccines have also been evaluated for the immunotherapy of established HSV infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.16.1.96-113.2003

Cites

297 of 297 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV
LaCasse, R. A., Follis, K. E., Trahey, M., et al. (1999) · Science · doi:10.1126/science.283.5400.357 · Cited by 211
Retracted
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,580
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1
McGeoch, D. J., Dalrymple, M. A., Davison, A. J., Dolan, A., Frame, M. C., McNab, D., Perry, L. J., Scott, J. E., & Taylor, P. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-7-1531 · Cited by 1,618
Herpes Simplex Viruses
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,159
Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family
Montgomery, R. I., Warner, M. S., Lum, B. J., & Spear, P. G. (1996) · Cell · doi:10.1016/s0092-8674(00)81363-x · Cited by 1,099
Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity
Liu, Y.-J. (2001) · Cell · doi:10.1016/s0092-8674(01)00456-1 · Cited by 1,021
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
Markert, J. M., Medlock, M. D., Rabkin, S. D., Gillespie, G. Y., Todo, T., Hunter, W. D. G., Palmer, C. A., Feigenbaum, F., Tornatore, C., Tufaro, F., et al. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301205 · Cited by 976
Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications
Corey, L., ADAMS, H. G., BROWN, Z. A., & HOLMES, K. K. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-6-958 · Cited by 928
Self-citation
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 828
Herpes simplex virus turns off the TAP to evade host immunity
Hill, A. B., Jugovic, P., York, L., Russ, G., Bennink, J., Yewdell, J. W., Ploegh, H. L., & Johnson, D. C. (1995) · Nature · doi:10.1038/375411a0 · Cited by 802
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S. L., Tyring, S. K., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 791
The Acquisition of Herpes Simplex Virus during Pregnancy
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J. N., Maslow, A. S., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 778
Self-citation
Type I Interferons Keep Activated T Cells Alive
Marrack, P., Kappler, J. W., & Mitchell, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.521 · Cited by 763
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator
Mauri, D. N., Ebner, R., Montgomery, R. I., Kochel, K. D., Cheung, T. C., Yu, G.-L., Ruben, S. M., Murphy, M., Eisenberg, R. J., Cohen, G. H., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80455-0 · Cited by 757
Selective Expression of an Interleukin-12 Receptor Component by Human T Helper 1 Cells
Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U., & Sinigaglia, F. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.825 · Cited by 746
Herpes simplex virus turns off the TAP to evade host immunity
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90181-7 · Cited by 737
Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in Culture
Chou, J., Kern, E. R., Whitley, R. J., & Roizman, B. (1990) · Science · doi:10.1126/science.2173860 · Cited by 711
Herpes Simplex Viruses
Whitley, R. J., & Roizman, B. (2002) · ASM Press eBooks · doi:10.1002/0471203076.emm0597 · Cited by 702
Herpes simplex virus type 1 in brain and risk of Alzheimer's disease
Itzhaki, R. F., Lin, W., Shang, D., Wilcock, G. K., Faragher, B. E., & Jamieson, G. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10149-5 · Cited by 671
Replication of hepatitis C virus
Bartenschlager, R. F. W., & Lohmann, V. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1631 · Cited by 612
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes
York, I. A., Roop, C., Andrews, D. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90215-1 · Cited by 565
T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients
Riddell, S. R., Elliott, M., Lewinsohn, D. A., Gilbert, M. J., Wilson, L., Manley, S. A., Lupton, S. D., Overell, R. W., Reynolds, T. C., Corey, L., et al. (1996) · Nature Medicine · doi:10.1038/nm0296-216 · Cited by 564
Self-citation
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera
Ashley, R. L., Militoni, J., Lee, F., Nahmias, A. J., & Corey, L. (1988) · Journal of Clinical Microbiology · doi:10.1128/jcm.26.4.662-667.1988 · Cited by 539
Self-citation
Three Classes of Cell Surface Receptors for Alphaherpesvirus Entry
Spear, P. G., Eisenberg, R. J., & Cohen, G. H. (2000) · Virology · doi:10.1006/viro.2000.0529 · Cited by 523
A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2
Langenberg, A. G. M., Corey, L., Ashley, R. L., Leong, W. P., & Straus, S. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911043411904 · Cited by 508
Self-citation
Virologic Characteristics of Subclinical and Symptomatic Genital Herpes Infections
Wald, A., Zeh, J. E., Selke, S., Ashley, R. L., & Corey, L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509213331205 · Cited by 504
Self-citation
Molecular Mimicry by Herpes Simplex Virus-Type 1: Autoimmune Disease After Viral Infection
Zhao, Z.-S., Granucci, F., Yeh, L., Schaffer, P. A., & Cantor, H. (1998) · Science · doi:10.1126/science.279.5355.1344 · Cited by 503
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 497
Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection
Corey, L., Langenberg, A. G. M., Ashley, R. L., Sekulovich, R. E., Izu, A., Douglas, J. M., Handsfield, H. H., Warren, T. J., Marr, L., Tyring, S. K., et al. (1999) · JAMA · doi:10.1001/jama.282.4.331 · Cited by 490
Self-citation
Risk Factors for the Sexual Transmission of Genital Herpes
MERTZ, G. J., Benedetti, J., Ashley, R. L., Selke, S., & Corey, L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-3-197 · Cited by 473
Self-citation
Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor.
Brown, Z. A., Benedetti, J., Ashley, R., Burchett, S., Selke, S., Berry, S., Vontver, L. A., & Corey, L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105023241804 · Cited by 473
Self-citation
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113799 · Cited by 454
Vaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
Benedetti, J., Corey, L., & Ashley, R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-11-199412010-00004 · Cited by 425
Self-citation
Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor HveA
Carfı́, A., Willis, S. H., Whitbeck, J. C., Krummenacher, C., Cohen, G. H., Eisenberg, R. J., & Wiley, D. C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00298-2 · Cited by 391
The skin immune system: progress in cutaneous biology
Bos, J. D., & Kapsenberg, M. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90062-p · Cited by 390
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted
Forrester, A., Farrell, H. E., Wilkinson, G. W. G., Kaye, J. F., Davis-Poynter, N. J., & Minson, T. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.341-348.1992 · Cited by 389
Cd8+ T Cells Can Block Herpes Simplex Virus Type 1 (HSV-1) Reactivation from Latency in Sensory Neurons
Liu, T., Khanna, K. M., Chen, X., Fink, D. J., & Hendricks, R. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1459 · Cited by 385
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
Kaul, R., Plummer, F. A., Kimani, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1602 · Cited by 385
Viral mechanisms of immune evasion
Alcamı́, A., Alcamı́, A., & Koszinowski, U. H. (2000) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01830-8 · Cited by 363
The Genome Sequence of Herpes Simplex Virus Type 2
Dolan, A., Jamieson, F. E., Cunningham, C., Barnett, B. C., & McGeoch, D. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2010-2021.1998 · Cited by 355
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
Klenerman, P., & Zinkernagel, R. M. (1998) · Nature · doi:10.1038/28860 · Cited by 349
Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus receptor, in cleft lip/palate-ectodermal dysplasia
Suzuki, K., Hu, D. P., Bustos, T., Zlotogora, J., Richieri‐Costa, A., Helms, J. A., & Spritz, R. A. (2000) · Nature Genetics · doi:10.1038/78119 · Cited by 332
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1
McGeoch, D. J., Dolan, A., Donald, S., & Brauer, D. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.4.1727 · Cited by 332
A Newly Identified Member of the Tumor Necrosis Factor Receptor Superfamily with a Wide Tissue Distribution and Involvement in Lymphocyte Activation
Kwon, B. S., Tan, K. B., Ni, J., Lee, Z. H., Kim, K. K., Kim, Y.-J., Wang, S., Gentz, R., Yu, G., Harrop, J., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14272 · Cited by 303
MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
Ott, G. S., Barchfeld, G. L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P., & Nest, G. V. (1995) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-1823-5_10 · Cited by 298
Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1
Marsters, S. A., Ayres, T. M., Skubatch, M., Gray, C. L., Rothe, M., & Ashkenazi, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14029 · Cited by 295
Mature Dendritic Cells Infected with Herpes Simplex Virus Type 1 Exhibit Inhibited T-Cell Stimulatory Capacity
Kruse, M., Rosorius, O., Krätzer, F., Stelz, G., Kuhnt, C., Schuler, G., Hauber, J., & Steinkasserer, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7127-7136.2000 · Cited by 277
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.
Koelle, D. M., Posavad, C. M., Barnum, G., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1758 · Cited by 264
Self-citation
Frequency of Acquisition of First-episode Genital Infection with Herpes Simplex Virus from Symptomatic and Asymptomatic Source Contacts
MERTS, G. J., Schmidt, O. W., Jourden, J., Guinan, M. E., Remington, M. L., FAHBLANDER, A., Winter, C., Holmes, K. K., & Corey, L. (1985) · Sexually Transmitted Diseases · doi:10.1097/00007435-198501000-00007 · Cited by 255
Self-citation
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
Pass, R. F., Duliège, A., Boppana, S. B., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315022 · Cited by 250
In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020: Construction and Evaluation in Rodents
Meignier, B., Longnecker, R., & Roizman, B. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.3.602 · Cited by 249
Gamma Interferon Can Prevent Herpes Simplex Virus Type 1 Reactivation from Latency in Sensory Neurons
Liu, T., Khanna, K. M., Carriere, B. N., & Hendricks, R. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11178-11184.2001 · Cited by 243
Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons.
Simmons, A., & Tscharke, D. C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.175.5.1337 · Cited by 240
Evolution of recurrent herpes simplex lesions. An immunohistologic study.
Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F., & Merigan, T. C. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111678 · Cited by 239
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration
Highlander, S. L., Sutherland, S., Gage, P. J., Johnson, D. C., Levine, M., & Glorioso, J. C. (1987) · Journal of Virology · doi:10.1128/jvi.61.11.3356-3364.1987 · Cited by 237
Immunity causing blindness: five different paths to herpes stromal keratitis
Streilein, J. W., Dana, M. R., & Ksander, B. R. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01114-6 · Cited by 234
Constitutive Expression of LIGHT on T Cells Leads to Lymphocyte Activation, Inflammation, and Tissue Destruction
Shaikh, R. B., Santee, S. M., Granger, S. W., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6330 · Cited by 234
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
Leib, D. A., Machalek, M. A., Williams, B. R. G., Silverman, R. H., & Virgin, H. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100415697 · Cited by 230
Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus
Kramer, M. F., & Coen, D. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1389-1399.1995 · Cited by 230
Peroxisome proliferator-activated receptor γ activators affect the maturation of human monocyte-derived dendritic cells
Gosset, P., Charbonnier, A.-S., Delerive, P., Fontaine, J., Staels, B., Pestel, J., Tonnel, A., & Trottein, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10 · Cited by 225
Intranasal Immunization with CpG Oligodeoxynucleotides as an Adjuvant Dramatically Increases IgA and Protection Against Herpes Simplex Virus-2 in the Genital Tract
Gallichan, W. S., Woolstencroft, R. N., Guarasci, T., McCluskie, M. J., Davis, H. L., & Rosenthal, K. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.3451 · Cited by 220
Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
Kuklin, N. A., Daheshia, M., Karem, K. L., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3138-3145.1997 · Cited by 208
Asymptomatic Reactivation of Herpes Simplex Virus in Women after the First Episode of Genital Herpes
Koelle, D. M., Benedetti, J., Langenberg, A. G. M., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-433 · Cited by 207
Self-citation
Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8+ T Cell Response
Goldsmith, K., Chen, W., Johnson, D. C., & Hendricks, R. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.341 · Cited by 206
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes
Straus, S. E., Savarese, B., Krause, P. R., Kost, R. G., Meier, J. L., Corey, L., Barnum, G., Burke, R. L., Sekulovich, R. E., Adair, S. F., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92581-x · Cited by 203
Self-citation
Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration
Fuller, A. O., Santos, R. E., & Spear, P. G. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3435-3443.1989 · Cited by 200
Prospects for Control of Herpes Simplex Virus Disease through Immunization
Stanberry, L. R., Cunningham, A. L., Mindel, A., Scott, L. L., Spruance, S. L., Aoki, F. Y., & Lacey, C. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313687 · Cited by 200
Frequencies of Memory T Cells Specific for Varicella‐Zoster Virus, Herpes Simplex Virus, and Cytomegalovirus by Intracellular Detection of Cytokine Expression
Asanuma, H., Sharp, M., Maecker, H. T., Maino, V. C., & Arvin, A. M. (2000) · The Journal of Infectious Diseases · doi:10.1086/315347 · Cited by 199
IL-12 Gene as a DNA Vaccine Adjuvant in a Herpes Mouse Model: IL-12 Enhances Th1-Type CD4+ T Cell-Mediated Protective Immunity Against Herpes Simplex Virus-2 Challenge
Sin, J., Kim, J. J., Arnold, R. L., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.5.2912 · Cited by 197
T Lymphocytes Are Required for Protection of the Vaginal Mucosae and Sensory Ganglia of Immune Mice Against Reinfection with Herpes Simplex Virus Type 2
Milligan, G. N., Bernstein, D. I., & Bourne, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.6093 · Cited by 192
Detection of Herpes Simplex Virus DNA in Cutaneous Lesions of Erythema Multiforme
Brice, S. L., Krzemien, D., Weston, W. L., & Huff, J. C. (1989) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12277397 · Cited by 188
Dendritic Cells Internalize Vaccine Adjuvant after Intramuscular Injection
Dupuis, M., Murphy, T. J., Higgins, D., Ugozzoli, M., Nest, G. V., Ott, G. S., & McDonald, D. M. (1998) · Cellular Immunology · doi:10.1006/cimm.1998.1283 · Cited by 185
Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time
Benedetti, J., Zeh, J. E., & Corey, L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00004 · Cited by 181
Self-citation
ATAR, a Novel Tumor Necrosis Factor Receptor Family Member, Signals through TRAF2 and TRAF5
Hsu, H., Solovyev, I., Colombero, A. M., Elliott, R., Kelley, M. J., & Boyle, W. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13471 · Cited by 180
A Recombinant Glycoprotein Vaccine for Herpes Simplex Type 2: Safety and Efficacy
Langenberg, A. G. M., Burke, R. L., Adair, S. F., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00001 · Cited by 179
Immature Monocyte-Derived Dendritic Cells Are Productively Infected with Herpes Simplex Virus Type 1
Mikloška, Z., Bosnjak, L., & Cunningham, A. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.5958-5964.2001 · Cited by 179
A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus
Chen, S. H., Kramer, M. F., Schaffer, P. A., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5878-5884.1997 · Cited by 178
Demonstration of Exogenous Genital Reinfection with Herpes Simplex Virus Type 2 by Restriction Endonuclease Fingerprinting of Viral DNA
Buchman, T. G., Roizman, B., & Nahmias, A. J. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.3.295 · Cited by 175
Sorting out the new HSV type specific antibody tests
Ashley, R. L. (2001) · Sexually Transmitted Infections · doi:10.1136/sti.77.4.232 · Cited by 171
Immunotherapy of Recurrent Genital Herpes with Recombinant Herpes Simplex Virus Type 2 Glycoproteins D and B: Results of a Placebo‐Controlled Vaccine Trial
Straus, S. E., Wald, A., Kost, R. G., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514103 · Cited by 169
Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors
Scognamiglio, P., Accapezzato, D., Casciaro, M., Cacciani, A., Artini, M., Bruno, G., Chircu, M. L., Sidney, J., Southwood, S., Abrignani, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6681 · Cited by 163
The Probability of In Vivo Reactivation of Herpes Simplex Virus Type 1 Increases with the Number of Latently Infected Neurons in the Ganglia
Sawtell, N. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6888-6892.1998 · Cited by 163
Erythema multiforme: Clinical, histopathologic, and immunologic study
Howland, W. W., Golttz, L. E., Weston, W. L., et al. (1984) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(84)80090-0 · Cited by 157
A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
Boursnell, M. E. G., Entwisle, C., Blakeley, D. M., et al. (1997) · The Journal of Infectious Diseases · doi:10.1093/infdis/175.1.16 · Cited by 157
Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
Vasilakos, J. P., Smith, R. M., Gibson, S. J., Lindh, J. M., Pederson, L. K., Reiter, M. J., Smith, M. H., & Tomai, M. A. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1689 · Cited by 155
In Vivo Behavior of Genetically Engineered Herpes Simplex Viruses R7017 and R7020. II. Studies in Immunocompetent and Immunosuppressed Owl Monkeys (Aotus trivirgatus)
Meignier, B., Martin, B., Whitley, R. J., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/162.2.313 · Cited by 155
In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model
Sin, J., Kim, J. J., Boyer, J., Ciccarelli, R. B., Higgins, T. J., & Weiner, D. B. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.501-509.1999 · Cited by 154
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells
Cantoni, C., Bottino, C., Augugliaro, R., Morelli, L., Marcenaro, E., Castriconi, R., Vitale, M., Pende, D., Sivori, S., Millo, R., et al. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199910)29:10 · Cited by 153
Direct Recovery of Herpes Simplex Virus (HSV)-Specific T Lymphocyte Clones from Recurrent Genital HSV-2 Lesions
Koelle, D. M., Abbo, H., Peck, A., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.5.956 · Cited by 152
Self-citation
Systemic cytokine profiles in BALB/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants.
Valensi, J. P., Carlson, J. R., & Nest, G. A. V. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4029 · Cited by 146
Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8 + cytotoxic T lymphocyte responses
Posavad, C. M., Koelle, D. M., Shaughnessy, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10289 · Cited by 143
Self-citation
Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled
Tigges, M. A., Leng, S. X., Johnson, D. C., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3901 · Cited by 142
Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration
Baldridge, J. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00572-1 · Cited by 136
Protective Vaccination Against Primary And Recurrent Disease Caused By Herpes Simplex Virus (HSV) Type 2 Using A Genetically Disabled HSV-1
McLean, C. S., Ertürk, M., Jennings, R., Challanáin, D. N., Minson, A. C., Duncan, I. A., Boursnell, M. E. G., & Inglis, S. C. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1100 · Cited by 135
The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' Cells
Burns, R. P., Ferbel, B., Tomai, M. A., et al. (2000) · Clinical Immunology · doi:10.1006/clim.1999.4804 · Cited by 132
Double-Blind, Placebo-Controlled Trial of a Herpes Simplex Virus Type 2 Glycoprotein Vaccine in Persons at High Risk for Genital Herpes Infection
MERTZ, G. J., Ashley, R. L., Burke, R. L., et al. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.4.653 · Cited by 131
Analysis of the relationship between viral infection and autoimmune disease.
Panoutsakopoulou, V., Sanchirico, M., Huster, K., Jansson, M., Granucci, F., Shim, D., Wucherpfennig, K., & Cantor, H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00172-8 · Cited by 130
Herpes simplex virus vaccines
Bernstein, D. I., & Stanberry, L. R. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00434-4 · Cited by 129
Anterograde Transport of Herpes Simplex Virus Type 1 in Cultured, Dissociated Human and Rat Dorsal Root Ganglion Neurons
Saksena, M. M., Armati, P. J., Boadle, R. A., Holland, D. J., & Cunningham, A. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1827-1839.2000 · Cited by 129
In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor
Nagashunmugam, T., Lubinski, J. M., Wang, L., Goldstein, L. T., Weeks, B. S., Sundaresan, P., Kang, E. H., Dubin, G. O., & Friedman, H. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.7.5351-5359.1998 · Cited by 129
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions
Koelle, D. M., Corey, L., Burke, R. L., et al. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2803-2810.1994 · Cited by 127
Self-citation
A Null Mutation in the Gene Encoding the Herpes Simplex Virus Type 1 UL37 Polypeptide Abrogates Virus Maturation
Desai, P. J., Sexton, G. L., McCaffery, J. M., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.21.10259-10271.2001 · Cited by 126
Primary and Secondary Syphilis Lesions Contain mRNA for Thl Cytokines
Voorhis, W. C. V., Barrett, L. K., Koelle, D. M., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.2.491 · Cited by 126
Self-citation
Risk of Acquisition of Genital Herpes Simplex Virus Type 2 in Sex Partners of Persons with Genital Herpes: A Prospective Couple Study
Bryson, Y. J., Dillon, M., Bernstein, D. I., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.4.942 · Cited by 125
Herpes Simplex Virus Type 2 ICP47 Inhibits Human TAP but Not Mouse TAP
Tomazin, R., van Schoot, N. E. G., Goldsmith, K., Jugovic, P., Sempé, P., Früh, K., & Johnson, D. C. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2560-2563.1998 · Cited by 125
Dendritic Cell Maturation and Subsequent Enhanced T-Cell Stimulation Induced with the Novel Synthetic Immune Response Modifier R-848
Ahonen, C. L., Gibson, S. J., Smith, R. M., Pederson, L. K., Lindh, J. M., Tomai, M. A., & Vasilakos, J. P. (1999) · Cellular Immunology · doi:10.1006/cimm.1999.1555 · Cited by 123
In Vivo Role of Complement-Interacting Domains of Herpes Simplex Virus Type 1 Glycoprotein Gc
Lubinski, J. M., Wang, L., Mastellos, D. C., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1637 · Cited by 123
HLA-DQ Tetramers Identify Epitope-Specific T Cells in Peripheral Blood of Herpes Simplex Virus Type 2-Infected Individuals: Direct Detection of Immunodominant Antigen-Responsive Cells
Kwok, W. W., Liu, A. W., Novak, E. J., Gebe, J. A., Ettinger, R. A., Nepom, G. T., Reymond, S. N., & Koelle, D. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4244 · Cited by 120
Self-citation
Alpha and Gamma Interferons Inhibit Herpes Simplex Virus Type 1 Infection and Spread in Epidermal Cells after Axonal Transmission
Mikloška, Z., & Cunningham, A. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.23.11821-11826.2001 · Cited by 119
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration
Highlander, S. L., Cai, W., Person, S., et al. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.1881-1888.1988 · Cited by 118
Immunization with a Single Major Histocompatibility Complex Class I-Restricted Cytotoxic T-Lymphocyte Recognition Epitope of Herpes Simplex Virus Type 2 Confers Protective Immunity
Blaney, J. E., Nobusawa, E., Brehm, M. A., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9567-9574.1998 · Cited by 117
CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells
Koelle, D. M., Chen, H. B., Gavin, M. A., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4049 · Cited by 116
Self-citation
Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells
Raftery, M., Behrens, C. K., Müller, A., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.8.1103 · Cited by 114
Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-γ is Expressed in HAEM Lesions and Tumor Necrosis Factor-α in Drug-Induced Erythema Multiforme Lesions
Kokuba, H., Aurelian, L., & Burnett, J. W. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00754.x · Cited by 113
Herpes simplex virus antiviral drug resistance — current trends and future prospects
Field, H. J. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00169-4 · Cited by 110
Resistance to herpes stromal keratitis conferred by an lgG2a-derived peptide
Avery, A. C., Zhao, Z.-S., Rodríguez-García, A., Bikoff, E. K., Soheilian, M., Foster, C. S., & Cantor, H. (1995) · Nature · doi:10.1038/376431a0 · Cited by 109
Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells
Martin, S. J., Moss, B. A., Berman, P. W., et al. (1987) · Journal of Virology · doi:10.1128/jvi.61.3.726-734.1987 · Cited by 108
Induction of Interferon-α by Glycoprotein D of Herpes Simplex Virus: A Possible Role of Chemokine Receptors
Ankel, H., Westra, D. F., Welling‐Wester, S., & Lebon, P. (1998) · Virology · doi:10.1006/viro.1998.9432 · Cited by 108
Detection of a Herpes Simplex Viral Antigen in Skin Lesions of Erythema Multiforme
Orton, P. W., HUFF, J. C., TONNESEN, M. G., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-48 · Cited by 107
Construction, Phenotypic Analysis, and Immunogenicity of a UL5/UL29 Double Deletion Mutant of Herpes Simplex Virus 2
Costa, X. J. D., Kramer, M. F., Zhu, J., Brockman, M. A., & Knipe, D. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7963-7971.2000 · Cited by 106
Detection of HSV-specific DNA in biopsy tissue of patients with erythema multiforme by polymerase chain reaction
Aslanzadeh, J., Helm, K. F., Espy, M. J., et al. (1992) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1992.tb08397.x · Cited by 103
Prime-Boost Immunization with DNA Vaccine: Mucosal Route of Administration Changes the Rules
Eo, S. K., Gieryńska, M. M., Abo-Kamar, A. M., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5473 · Cited by 103
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
Heineman, T. C. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00088-2 · Cited by 101
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens
Tigges, M. A., Koelle, D. M., Hartog, K., et al. (1992) · Journal of Virology · doi:10.1128/jvi.66.3.1622-1634.1992 · Cited by 101
Self-citation
Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot Study
Spruance, S. L., Tyring, S. K., Smith, M. H., & Meng, T. (2001) · The Journal of Infectious Diseases · doi:10.1086/322007 · Cited by 99
Erythema Multiforme and Toxic Epidermal Necrolysis: A Comparative Study
Paquet, P., & Pierard, G. (1997) · American Journal of Dermatopathology · doi:10.1097/00000372-199704000-00005 · Cited by 97
gamma Interferon production appears to predict time of recurrence of herpes labialis.
Cunningham, A. L., & Merigan, T. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.5.2397 · Cited by 96
In Vivo Production of Cytokines and (C-C) Chemokines in Human Recurrent Herpes Simplex Lesions--Do Herpes Simplex Virus-Infected Keratinocytes Contribute to Their Production?
Miklos, Z., Danis, V. A., Adams, S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515236 · Cited by 96
Requirements for the Induction of Interleukin-6 by Herpes Simplex Virus-Infected Leukocytes
Paludan, S. (2001) · Journal of Virology · doi:10.1128/jvi.75.17.8008-8015.2001 · Cited by 96
Bystander Activation Involving T Lymphocytes in Herpetic Stromal Keratitis
Kaistha, S. D., Zheng, M., Lee, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2902 · Cited by 95
Seroprevalence and Incidence of Sexually Transmitted Diseases in a Rural Ugandan Population
Wagner, H. U., Dyck, E. V., Roggen, E., et al. (1994) · International Journal of STD & AIDS · doi:10.1177/095646249400500509 · Cited by 95
Incoming Human Cytomegalovirus pp65 (UL83) Contained in Apoptotic Infected Fibroblasts Is Cross-Presented to CD8+T Cells by Dendritic Cells
Arrode, G., Boccaccio, C., Lulé, J., Allart, S., Moinard, N., Abastado, J., Alam, A., & Davrinche, C. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10018-10024.2000 · Cited by 95
The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge
Peng, T., Ponce-de-León, M., Jiang, H., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.65-72.1998 · Cited by 94
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
Zarling, J. M., Moran, P. A., Burke, R. L., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4669 · Cited by 93
Human Cytomegalovirus pp65- and Immediate Early 1 Antigen-Specific HLA Class I-Restricted Cytotoxic T Cell Responses Induced by Cross-Presentation of Viral Antigens
Tabi, Z., Moutaftsi, M., & Borysiewicz, L. K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5695 · Cited by 93
Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans
Koelle, D. M., Reymond, S. N., Chen, H., Kwok, W. W., McClurkan, C. L., Gyaltsong, T., Petersdorf, E. W., Rotkis, W. M., Talley, A. R., & Harrison, D. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.10930-10938.2000 · Cited by 93
Self-citation
The role of the UL41 gene of herpes simplex virus type 1 in evasion of non-specific host defence mechanisms during primary infection
Suzutani, T., Nagamine, M., Shibaki, T., Ogasawara, M., Yoshida, I., Daikoku, T., Nishiyama, Y., & Azuma, M. (2000) · Microbiology · doi:10.1099/0022-1317-81-7-1763 · Cited by 93
Genetic Analysis of the Role of Herpes Simplex Virus Type 1 Glycoprotein K in Infectious Virus Production and Egress
Foster, T. P., & Kousoulas, K. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8457-8468.1999 · Cited by 92
Recognition of Herpes Simplex Virus Type 2 Tegument Proteins by CD4 T Cells Infiltrating Human Genital Herpes Lesions
Koelle, D. M., Frank, J. M., Johnson, M., et al. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7476-7483.1998 · Cited by 92
Self-citation
Anterograde Transport of Herpes Simplex Virus Proteins in Axons of Peripheral Human Fetal Neurons: an Immunoelectron Microscopy Study
Holland, D. J., Saksena, M. M., Boadle, R. A., Armati, P. J., & Cunningham, A. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8503-8511.1999 · Cited by 91
New developments in the epidemiology, natural history and management of genital herpes
Stanberry, L. R., Cunningham, A. L., MERTZ, G. J., Mindel, A., PETERS, B., Reitano, M. V., Sacks, S. H., Wald, A., Wassilew, S. W., & Woolley, P. D. (1999) · Antiviral Research · doi:10.1016/s0166-3542(99)00004-2 · Cited by 91
Evidence of Latency and Reactivation of Both Herpes Simplex Virus (HSV)‐1 and HSV‐2 in the Genital Region
Sucato, G. S., Wald, A., Wakabayashi, E., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515261 · Cited by 91
Mucosal Immunity to Herpes Simplex Virus Type 2 Infection in the Mouse Vagina Is Impaired by In Vivo Depletion of T Lymphocytes
Parr, M. B., & Parr, E. L. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2677-2685.1998 · Cited by 91
The Major Neutralizing Antigenic Site on Herpes Simplex Virus Glycoprotein D Overlaps a Receptor-Binding Domain
Whitbeck, J. C., Muggeridge, M. I., Rux, A. H., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9879-9890.1999 · Cited by 90
Presence of VZV and HSV-1 DNA in Human Nodose and Celiac Ganglia
Gilden, D. H., Gesser, R., Smith, J., Wellish, M., LaGuardia, J. J., Cohrs, R. J., & Mahalingam, R. (2001) · Virus Genes · doi:10.1023/a:1011883919058 · Cited by 88
Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloška, Z., & Cunningham, A. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-2-353 · Cited by 88
High frequency of CD8+ cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes
Posavad, C. M., Koelle, D. M., & Corey, L. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8165-8168.1996 · Cited by 88
Self-citation
Role of Mucosal Immunity in Herpes Simplex Virus Infection
Kuklin, N. A., Daheshia, M., Chun, S., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5998 · Cited by 87
Humoral immune response to HSV‐1 and HSV‐2 viral proteins in patients with primary genital herpes
Ashley, R. L., Benedetti, J., & Corey, L. (1985) · Journal of Medical Virology · doi:10.1002/jmv.1890170208 · Cited by 85
Self-citation
Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection
Costa, X. J. D., Jones, C., & Knipe, D. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6994 · Cited by 84
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.
Koelle, D. M., Tigges, M. A., Burke, R. L., et al. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116317 · Cited by 84
Self-citation
Herpes Simplex Virus-Induced Keratitis: Evaluation of the Role of Molecular Mimicry in Lesion Pathogenesis
Kaistha, S. D., Lee, S., Zheng, M., Song, B., Knipe, D. M., Kapp, J. A., & Rouse, B. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3077-3088.2001 · Cited by 84
Molecular Mechanisms of B Lymphocyte Activation by the Immune Response Modifier R-848
Bishop, G. A., Hsing, Y., Hostager, B. S., Jalukar, S. V., Ramirez, L. M., & Tomai, M. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5552 · Cited by 84
Oral acyclovir for the prevention of herpes-associated erythema multiforme
Lemak, M. A., Duvic, M., & Bean, S. F. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70141-2 · Cited by 83
Construction and Characterization of a Replication-Defective Herpes Simplex Virus 2 ICP8 Mutant Strain and Its Use in Immunization Studies in a Guinea Pig Model of Genital Disease
Costa, X. J. D., Bourne, N., Stanberry, L. R., et al. (1997) · Virology · doi:10.1006/viro.1997.8564 · Cited by 82
Modulation of Immunity against Herpes Simplex Virus Infection via Mucosal Genetic Transfer of Plasmid DNA Encoding Chemokines
Eo, S. K., Lee, S., Chun, S., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.2.569-578.2001 · Cited by 82
Herpes Simplex Virus Protein Targets for CD4 and CD8 Lymphocyte Cytotoxicity in Cultured Epidermal Keratinocytes Treated with Interferon-γ
Mikloška, Z., Kesson, A. M., Penfold, M. E. T., et al. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.7 · Cited by 82
IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.
Keadle, T. L., Usui, N., Laycock, K. A., et al. (2000) · PubMed · Cited by 81
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection
Nguyen, L., Knipe, D. M., & Finberg, R. W. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7067-7072.1992 · Cited by 81
Granzyme A, a Noncytolytic Component of CD8+Cell Granules, Restricts the Spread of Herpes Simplex Virus in the Peripheral Nervous Systems of Experimentally Infected Mice
Pereira, R. A., Simon, M. M., & Simmons, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.2.1029-1032.2000 · Cited by 80
Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells
Manickan, E., Francotte, M., Kuklin, N. A., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4711-4716.1995 · Cited by 78
Herpes simplex virus type I infection of the CNS induces major histocompatibility complex antigen expression on rat microglia
Weinstein, D. L., Walker, D. G., Akiyama, H., & McGeer, P. L. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260107 · Cited by 77
Erythema multiforme lesions are associated with expression of a herpes simplex virus (HSV) gene and qualitative alterations in the HSV-specific T-cell response
Kokuba, Imafuku, Huang, et al. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02260.x · Cited by 76
A prophylactic hepatitis B vaccine with a novel adjuvant system
Thoelen, S., Clercq, N. D., & Tornieporth, N. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00462-x · Cited by 74
The Quantity of Latent Viral DNA Correlates with the Relative Rates at Which Herpes Simplex Virus Types 1 and 2 Cause Recurrent Genital Herpes Outbreaks
Lekstrom-Himes, J. A., Pesnicak, L., & Straus, S. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2760-2764.1998 · Cited by 73
Neutralizing Antibodies Inhibit Axonal Spread of Herpes Simplex Virus Type 1 to Epidermal Cells In Vitro
Mikloška, Z., Sanna, P. P., & Cunningham, A. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5934-5944.1999 · Cited by 73
Persistent Elevated Expression of Cytokine Transcripts in Ganglia Latently Infected with Herpes Simplex Virus in the Absence of Ganglionic Replication or Reactivation
Chen, S., Garber, D. A., Schaffer, P. A., et al. (2000) · Virology · doi:10.1006/viro.2000.0643 · Cited by 72
Detection of Viral DNA Within Skin of Healed Recurrent Herpes Simplex Infection and Erythema Multiforme Lesions
Miura, S., Smith, C. C., Burnett, J. W., & Aurelian, L. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12495372 · Cited by 72
Mechanisms of Immunization with a Replication-Defective Mutant of Herpes Simplex Virus 1
Morrison, L. A., & Knipe, D. M. (1996) · Virology · doi:10.1006/viro.1996.0328 · Cited by 72
Evaluation of a Live Attenuated Recombinant Virus RAV 9395 as a Herpes Simplex Virus Type 2 Vaccine in Guinea Pigs
Spector, F., Kern, E. R., Palmer, J., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515278 · Cited by 71
Cutting Edge: A NK Complex-Linked Locus Governs Acute Versus Latent Herpes Simplex Virus Infection of Neurons
Pereira, R. A., Scalzo, A. A., & Simmons, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.5869 · Cited by 70
Difference in Incidence of Spontaneous Mutations between Herpes Simplex Virus Types 1 and 2
Sarisky, R. T., Nguyen, T., Duffy, K. E., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1524-1529.2000 · Cited by 68
Chronic Vulvar Ulceration in an Immunocompetent Woman Due to Acyclovir‐Resistant, Thymidine Kinase‐Deficient Herpes Simplex Virus
Swetter, S. M., Hill, E. L., Kern, E. R., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/514229 · Cited by 68
Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1
Friedman, H. M., Wang, L., Pangburn, M. K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4528 · Cited by 67
Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea
Ghebrekidan, H., Rudén, U., Cox, S. W., et al. (1999) · Journal of Clinical Virology · doi:10.1016/s0928-0197(98)00064-6 · Cited by 67
Fas-Independent Cytotoxicity Mediated by Human CD4+ CTL Directed Against Herpes Simplex Virus-Infected Cells
Yasukawa, M., Ohminami, H., Yakushijin, Y., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6100 · Cited by 67
Monophosphoryl Lipid A and QS21 Increase CD8 T Lymphocyte Cytotoxicity to Herpes Simplex Virus-2 Infected Cell Proteins 4 and 27 Through IFN-γ and IL-12 Production
Mikloška, Z., Rückholdt, M., Ghadiminejad, I., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5167 · Cited by 66
Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy
Coukos, G., Makrigiannakis, A., Montas, S., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700130 · Cited by 66
Transcription from the Gene Encoding the Herpesvirus Entry Receptor Nectin-1 (HveC) in Nervous Tissue of Adult Mouse
Haarr, L., Shukla, D., Rødahl, E., Canto, M. C. D., & Spear, P. G. (2001) · Virology · doi:10.1006/viro.2001.1041 · Cited by 65
Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans, G. M. G. M., Remeijer, L., Mooy, C. M., et al. (2000) · PubMed · Cited by 65
The yeast cell wall, a dynamic structure engaged in growth and morphogenesis
Cabib, E., Drgon, T., Drgonová, J., Ford, R. A., & KOLLÁR, R. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250200 · Cited by 65
Herpes Simplex Viremia: Report of Eight Pediatric Cases and Review of the Literature
Stanberry, L. R., Floyd-Reising, S. A., Connelly, B. L., Alter, S. J., Gilchrist, M. J. R., Rubio, C., & Myers, M. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.401 · Cited by 64
Significance of Local Interferon in Recurrent Herpes Simplex Infection
Torseth, J. W., & Merigan, T. C. (1986) · The Journal of Infectious Diseases · doi:10.1093/infdis/153.5.979 · Cited by 64
Role as Antibody-Dependent Cellular Cytotoxicity in Defense Against Herpes Simplex Virus Infections
Kohl, S. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.108 · Cited by 63
Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro.
Cunningham, A. L., & Noble, J. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113908 · Cited by 63
Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands
Eo, S. K., Lee, S., Kumaraguru, U., et al. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00241-9 · Cited by 63
Protein-Specific Cervical Antibody Responses to Primary Genital Herpes Simplex Virus Type 2 Infections
Ashley, R. L., Corey, L., Dalessio, J., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.1.20 · Cited by 62
Self-citation
Herpes simplex virus thymidine kinase and specific stages of latency in murine trigeminal ganglia
Jacobson, J. G., Ruffner, K. L., Kosz‐Vnenchak, M., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.11.6903-6908.1993 · Cited by 61
Acyclovir Blocks Cytokine Gene Expression in Trigeminal Ganglia Latently Infected with Herpes Simplex Virus Type 1
Halford, W. P., Gebhardt, B. M., & Carr, D. J. J. (1997) · Virology · doi:10.1006/viro.1997.8806 · Cited by 61
A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8–23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection
Chabalgoity, J. A., Khan, C. M. A., Nash, A. A., et al. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.426965.x · Cited by 61
Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine
McLean, C. S., NíChallanáin, D., Duncan, I. A., et al. (1996) · Vaccine · doi:10.1016/0264-410x(95)00259-4 · Cited by 61
Identification and Characterization of Herpes Simplex Virus‐Specific CD4+T Cells in Corneas of Herpetic Stromal Keratitis Patients
Verjans, G. M. G. M., Remeijer, L., van Binnendijk, R. S., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/517382 · Cited by 61
Structural Features of Nectin-2 (HveB) Required for Herpes Simplex Virus Entry
Martinez, W. M., & Spear, P. G. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.11185-11195.2001 · Cited by 61
Leu-3+ T cells produce gamma-interferon in patients with recurrent herpes labialis.
Cunningham, A. L., & Merigan, T. C. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.132.1.197 · Cited by 60
The Influence Of Adjuvant On The Therapeutic Efficacy Of A Recombinant Genital Herpes Vaccine
Burke, R. L., Goldbeck, C., Ng, P., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1110 · Cited by 60
Induction and Enhancement of Immune Responses to Herpes Simplex Virus Type 2 in Humans by Use of a Recombinant Glycoprotein D Vaccine
Straus, S. E., Savarese, B., Tigges, M. A., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1045 · Cited by 59
Cell Surface Expression of H2 Antigens on Primary Sensory Neurons in Response to Acute but Not Latent Herpes Simplex Virus Infection In Vivo
Pereira, R. A., & Simmons, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6484-6489.1999 · Cited by 59
The in situ cellular immune response in acute herpes simplex encephalitis.
Sobel, R. A., Collins, A. B., Colvin, R. B., & Bhan, A. K. (1986) · PubMed Central · Cited by 58

Research works printed but not linked: 2

Corey L. and A. Wald. 1999. Genital herpes p. 285-312. In K. K. Holmes P. F. Sparling P. A. Mardh S. M. Lemon W. E. Stamm P. Piot and J. M. Wasserheit (ed.) Sexually transmitted diseases 3rd ed. McGraw-Hill Inc. New York N.Y.
Roizman B. and P. E. Pellett. The family herpesviridae: a brief introduction p. 2381-2397. In D. M. Knipe P. M. Howley and D. E. Griffin (ed.) Fields virology 4th ed. vol. 2. Lippincott Philadelphia Pa.

Sorted by citations

Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges
Ghosh, S., Brown, A. M., Jenkins, C., & Campbell, K. (2020) · Applied Biosafety · doi:10.1177/1535676019899502 · Cited by 218
The Acquired Immune System
Hedrick, S. M. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.020 · Cited by 122
Sustained elevation of kynurenic Acid in the cerebrospinal fluid of patients with herpes simplex virus type 1 encephalitis
Atlas, A., Franzen-Röhl, E., Söderlund, J., Jönsson, E. G., Samuelsson, M., Schwieler, L., Sköldenberg, B., & Engberg, G. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s13256 · Cited by 25

See all 263

Authors: Koelle, D. M., & Corey, L.
Affiliations: University of Washington (US)
Corresponding author: Koelle, David M.
ORCID: Koelle, David M.
Corey, Lawrence
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2003-01
Volume: 16
Issue: 1
Pages: 96-113
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.16.1.96-113.2003
PMC: PMC145296
OpenAlex: W2158636026
Cited by: 263
References: 297
Citations by year: 2026: 3 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 6 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 10 · 2016: 7 · 2015: 13 · 2014: 10 · 2013: 12 · 2012: 16
FWCI: 3.16
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Allergy and Infectious Diseases (R21AI050132, AI 30731, P01AI030731, R01AI050132, AI 50132)
Topics: Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: herpes simplex virus, herpes simplex virus type 1, herpes simplex virus type 2, herpes vaccine, subunit vaccine, glycoproteins, glycoprotein D, adjuvants, genital herpes, neonatal herpes, HIV transmission, asymptomatic viral shedding, live attenuated vaccine, cell-mediated immunity, neutralizing antibodies
MeSH terms: Forecasting, Herpes Simplex, Humans, Viral Vaccines, Simplexvirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks